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2The major energy source for most cells is glucose, from which ATP is generated 
via glycolysis and/or oxidative metabolism. Glucose deprivation activates AMP-
activated protein kinase (AMPK)
1
, but it has been unclear whether this occurs 
solely via changes in AMP or ADP, the classical activators of AMPK
2-5
. Here, we 
uncover a mechanism that triggers AMPK activation via an AMP/ADP-
independent mechanism sensing absence of FBP, with AMPK being
progressively activated as extracellular glucose and intracellular FBP decrease. 
When unoccupied by FBP, aldolases promote the formation of lysosomal 
complexes containing the v-ATPase, Ragulator, AXIN, LKB1 and AMPK, 
previously shown to be required for AMPK activation
6,7
. Knockdown of aldolases 
activates AMPK even in cells with abundant glucose, while the catalysis-
defective D34S aldolase mutant, which still binds FBP, blocks AMPK activation. 
Cell-free reconstitution assays show that addition of FBP disrupts association of 
AXIN/LKB1 with v-ATPase/Ragulator. Importantly, in some cell types
AMP:ATP/ADP:ATP ratios remain unchanged during acute glucose starvation,
and intact AMP-binding sites on AMPK are not required for AMPK activation. 
These results establish that aldolase, as well as a glycolytic enzyme, is a sensor of 
glucose availability that regulates AMPK.
Mammalian AMPK is activated by glucose deprivation, and it has often been 
assumed that impaired production of ATP from reduced glucose metabolism triggers 
this by increasing levels of AMP/ADP1,8. Recently, glucose deprivation has been shown 
to trigger formation of a complex at the lysosomal surface involving the v-ATPase, 
Ragulator, AXIN, LKB1 and AMPK, promoting AMPK phosphorylation by LKB1 at 
the activating phosphorylation site, Thr1726,7. However, these findings did not reveal 
3how glucose deprivation was sensed. To study this, we grew mouse embryo fibroblasts 
(MEFs) in standard medium, and then replaced the medium with reduced glucose, with 
other components unchanged. When glucose fell below 5 mM, progressive increases in 
immunoprecipitated AMPK activity occurred (Fig. 1a), correlating with 
phosphorylation of AMPK (p-AMPK) and its downstream target acetyl-CoA 
carboxylase (pACC) (Extended Data Fig. 1a). Surprisingly, this was not associated 
with any increase in cellular AMP:ATP or ADP:ATP ratios, although both were 
increased by the mitochondrial inhibitor berberine (Fig. 1b), which caused comparable 
AMPK/ACC phosphorylation as complete lack of glucose (Extended Data Fig. 1a). 
Similar results were obtained in HEK293T cells (Extended Data Fig. 1b, c). No
changes in adenine nucleotide ratios were observed in livers of mice starved for 16 h 
either, despite blood glucose dropping from 9 to 3 mM with accompanying increases in 
AMPK and ACC phosphorylation (Extended Data Fig. 1d-f). Combined starvation of 
MEFs for glucose, glutamine and serum (leaving them with no major carbon source) 
caused a rapid, 1.8-fold activation of AMPK within 15 min, followed by a much larger 
activation up to 2 h, while only the initial activation was observed if glutamine was still 
present (Fig. 1c); these changes correlated with phosphorylation of AMPK and ACC 
(Extended Data Fig. 1g, h). Intracellular AMP:ATP/ADP:ATP ratios were not 
significantly altered on removal of glucose alone, but on removing glucose and 
glutamine they increased after 30 min, correlating with the delayed AMPK activation 
(Fig. 1d; Extended Data Fig. 1i). Interestingly, we found the presence or absence of 
serum yielded different patterns of AMPK activation upon starvation for glucose or 
glucose plus glutamine (compare Fig. 1c and Extended Data Fig. 1j; see 
Supplementary Note 1). We also studied HEK293 cells that stably expressed FLAG-
4tagged wild type (WT) AMPK2 or the R531G (RG) mutant, which is not activated by 
treatments that increase cellular AMP/ADP9. In RG cells the rapid effect of removing 
glucose was still present, while the delayed effect of also removing glutamine was 
essentially absent (Fig. 1e-h; Extended Data Fig. 1k, l; Supplementary Note 2). Thus, 
glucose starvation activates AMPK by an AMP/ADP-independent mechanism, whereas 
removal of all carbon sources activates AMPK by the canonical AMP/ADP-dependent 
mechanism. The latter effect takes place after a delay of 20-30 minutes, which may 
represent the time taken to metabolize pyruvate in the medium and/or cellular nutrient 
reserves.
We next tested the effects of nutrient removal in AXIN-/- or LAMTOR1-/- MEFs, and 
found that acute (20 min) AMPK activation on removal of glucose or glucose plus 
glutamine was completely abolished, while the larger effects of removing both carbon 
sources at 2 h were unaffected (Fig. 2a, b; Extended Data Fig. 2a-c). Unlike WT 
AMPK2, re-introduction to knockout HEK293 cells of a G2A mutant (which 
prevents the N-myristoylation required for glucose starvation to cause AMPK
accumulation in “perinuclear speckles”8,10) did not restore the ability of glucose 
removal to activate AMPK or promote its translocation to lysosomes (Fig. 2c, d, 
Extended Data Fig. 2e, f). Similar results were obtained with AMPK1 (Extended 
Data Fig. 2g). By contrast, knock-down of CaMKK2 (the alternate upstream kinase 
for AMPK), expression of the AMPKβ2-S108A mutation that disrupts the “ADaM” 
binding site for allosteric activators such as A769662 and 99111,12, or of the LKB1-
C433S mutation that prevents the C-terminal farnesylation essential for maximal 
AMPK activation by energy stress13, had no effect on glucose starvation-induced 
AMPK activation (Fig. 2c, e; Extended Data Fig. 2d). Thus, by several criteria AMPK 
5activation by glucose removal occurs via a mechanism distinct from that involved in 
effects of energy stress or ADaM site ligands.
We next analyzed whether it is lack of glucose itself, or deficiency of a 
downstream metabolite (Extended Data Fig. 3a), that is responsible for AMPK 
activation. We first knocked down hexokinases (HK1/HK2) in HEK293T cells, which 
caused marked phosphorylation of AMPK and ACC even in high glucose (Fig. 3a).
However, intermediates in the pentose phosphate, serine biosynthesis or hexosamine 
pathways did not appear to be involved in AMPK regulation (Extended Data Fig. 3b-
d). Since AMPK was still activated by glucose deprivation even in medium containing 
1 mM pyruvate (Fig. 1; Extended Data Fig. 1), this left a glycolytic intermediate as the 
most likely regulator of AMPK. To address this, we used cell-free reconstitution 
assays involving complex formation between LAMTOR1, AXIN/LKB1 and AMPK6. 
Of the eleven intermediates from glucose to pyruvate, only FBP caused dissociation of 
AXIN/LKB1 and AMPK from LAMTOR1 in a fraction containing lysosomal 
membranes from glucose-starved MEFs (Fig. 3b; Extended Data Fig. 4a, b). The 
intracellular levels of FBP in mouse liver decreased markedly, from 9.7 ± 1.9 to 2.3 ±
1.2 µM, after starvation for 16 h (Extended Data Fig. 4c). Significantly, 10 µM FBP 
was able to cause complete dissociation of AXIN/LKB1 from LAMTOR1 (Fig. 3c).
Interestingly, the relationship between the concentrations of medium/plasma glucose 
and intracellular FBP was linear, both in MEFs and in liver in vivo (Extended Data Fig. 
4d-h).
To confirm that FBP represses AMPK activation, we introduced it into glucose-
starved cells permeabilized with streptolysin O (SLO) (Extended Data Fig. 4i). 
Addition of 10 µM FBP to the SLO-treated cells reduced AMPK phosphorylation
6under glucose starvation conditions (Fig. 3d). Interestingly, addition of intermediates 
upstream or downstream of FBP had similar effects except for pyruvate, which cannot 
be converted back to FBP in these cells (Extended Data Fig. 4j). However, 
intermediates upstream of FBP failed to suppress AMPK in SLO-permeabilized MEFs 
with knockdown of phosphofructokinase-1 (PFK1-KD, triple knockdown of PFKP, 
PFKM and PFKL), while intermediates downstream of FBP failed to suppress AMPK 
in SLO-permeabilized MEFs with knockdown of triose-phosphate isomerase (TPI-
KD) (Extended Data Fig. 4k, l). Furthermore, inhibiting FBP production by knocking 
down PFK1 or over-expressing fructose-1,6-bisphosphatase (FBP1) led to AMPK 
phosphorylation even in high glucose (Extended Data Fig. 5a, b). By contrast, 
promoting formation of FBP by over-expressing PFKP impaired AMPK activation in 
low glucose (Extended Data Fig. 5c). Knockdown of glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) had no effect on AMPK activation (Extended Data Fig. 5d).
We next asked which protein acts as the FBP sensor responsible for regulating 
AMPK. FBP is a substrate for aldolases (ALDOA-C) and an allosteric activator of 
pyruvate kinase (PK)14. Knockdown of aldolases causes cell death15, so ALDOA-C 
was first expressed under a doxycycline-inducible promoter before successive 
knockdown of the three endogenous isoenzymes, and doxycycline was then withdrawn 
to trigger almost complete aldolase depletion (Extended Data Fig. 6a-c). The triple 
knockdown (ALDO-TKD) caused AMPK activation even in high glucose (Fig. 4a; 
Extended Data Fig. 6d), while knocking down pyruvate kinases (PKM/PKLR) had no 
effect (Extended Data Fig. 6e). Triple knockdown of aldolases did not alter 
AMP:ATP/ADP:ATP levels (Extended Data Fig. 6f). Moreover, the effects of aldolase 
knockdown on AMPK activation and formation of AMPK-activating complexes were
7blocked in AXIN-/-, LAMTOR1-/- and LKB1-/- MEFs, but intact in CaMKK2-/- MEFs 
(Fig. 4b; Extended Data Fig. 6g-k and 7), confirming that aldolase exerts its effects 
through the lysosomal pathway. Importantly, FBP, even at 200 M, failed to dissociate 
AXIN/LKB1 from LAMTOR1 in light organelles isolated from glucose-starved, 
aldolase-deficient MEFs, or to block glucose starvation-induced AMPK activation in 
SLO-permeabilized, aldolase-deficient MEFs (Extended Data Fig. 6l, m). These results 
show that aldolase is required for FBP to prevent AMPK activation. Neither fructose-1-
phosphate (an alternate aldolase substrate) nor fructose-2,6-bisphosphate dissociated
AXIN/LKB1 from LAMTOR1 (Extended Data Fig. 6n), indicating that FBP is the 
unique intermediate that modulates aldolase to sense availability of glucose.
As final confirmation, we made use of an ALDOA mutation (D34S) that does not 
significantly affect Km for FBP, but dramatically reduces the kcat for conversion of FBP 
to DHAP and G3P16,17. FBP would therefore accumulate in the active site of this 
mutant, even when glucose availability was low. Supporting this, intracellular levels of 
FBP were slightly (but significantly) higher on glucose starvation of HEK293T cells 
expressing the D34S mutant than wild type ALDOA (Extended Data Fig. 8a). As 
expected, AMPK activation and formation of the Ragulator-AXIN/LKB1-AMPK 
complex were markedly impaired in HEK293T cells or ALDO-TKD MEFs expressing 
this mutant (Fig. 4c; Extended Data Fig. 8b, c). Furthermore, the levels of p-AMPK/p-
ACC were greatly reduced in starved mice injected with adenovirus expressing the 
D34S mutant compared to WT aldolase (Extended Data Fig. 8d). By contrast, when 
WT ALDOA was expressed in ALDO-TKD MEFs, it restored the response of AMPK 
to glucose availability, whereas the K230A mutant, which cannot form the initial Schiff 
base with FBP and would thus not undergo the conformational change induced by 
8FBP16,18,19, failed to do this (Fig. 4d; Extended Data Fig. 8e-g). 
This study defines FBP as the critical metabolite that signals glucose availability, 
and provides strong evidence that aldolases are the sensors that transmit the signal to 
AMPK. In MEFs and HEK293T cells, FBP was almost entirely derived from glucose
(Extended Data Fig. 9), and the intracellular concentrations of FBP correlated with 
medium/plasma glucose (Extended Data Fig. 4g, h). We propose that aldolase, as a 
natural FBP receptor, transmits the effects of glucose shortage to AMPK via the v-
ATPase-Ragulator-AXIN/LKB1 complex (Extended Data Fig. 10a). Knockdown of 
aldolase triggers formation of this complex even in high glucose, like pharmacological 
inhibition of v-ATPase6. Intriguingly, yeast and mammalian aldolases (Fba1 and 
ALDOA/B/C) physically interact with various subunits of the v-ATPase and are 
required for assembly and activity of the v-ATPase complex20-23. Our co-precipitation 
assays confirmed that aldolase interacts with v-ATPase and Ragulator in HEK293T 
cells (Extended Data Fig. 10b).
According to our model, aldolase would function as a surveillance system, sensing 
a fall in glucose availability before any fall in cellular energy status occurs, and 
activating AMPK in an AMP/ADP-independent manner. Aldolases may be ideal 
sensors of glucose availability because they are not saturated with FBP at normal 
glucose concentrations, so that FBP availability can be sensed across the entire 
physiological range (Supplementary Note 3). Once activated, AMPK would promote 
alternate catabolic pathways to generate ATP, such as fatty acid oxidation. Our 
findings that cellular energy status was not compromised by glucose removal in MEFs, 
unless glutamine was also removed, suggest that glucose-deprived MEFs simply switch 
to oxidative metabolism from glutamine. While AMP promotes the interaction of 
9AMPK with AXIN7, low, basal levels of AMP may be sufficient for AMPK activation 
via the lysosomal mechanism6, whereas higher concentrations (sufficient to cause 
binding at site 3, the low affinity site disrupted by the RG mutation24) may be necessary 
to trigger the canonical energy-sensing mechanism. Finally, since the budding yeast 
AMPK orthologue is activated by glucose starvation but is not regulated by AMP25, 
while the interaction between aldolase and v-ATPase is modulated by glucose 
availability in yeast22, we propose that the mechanism for AMPK regulation identified 
here may reflect its ancestral role in glucose sensing.
Online Content Methods, along with any additional Extended Data display items and
Source Data, are available in the online version of the paper; references unique to these 
sections appear only in the online paper.
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Figure legends
Figure 1 | Glucose deprivation activates AMPK via an AMP/ADP independent 
mechanism. a, MEFs were grown in full medium and then switched to medium 
containing reduced concentrations of glucose for 4 h, or full medium with 300 M 
berberine (Ber) for 1 h, and AMPK activity in immunoprecipitates was measured 
(mean ± SD, n = 3; asterisks show significant differences from 25 mM glucose). b, 
MEFs were incubated as in (a) and intracellular AMP:ATP/ADP:ATP ratios 
determined by LC:MS. Results are mean ± SD, n = 3; asterisks show significant 
differences from control with 25 mM glucose. c, MEFs were grown in full medium and 
then incubated overnight in the same medium but with 5 mM glucose. At time zero,
medium was removed and replaced with the same medium (+Glc+Gln), medium 
lacking glucose only (-Glc+Gln), or medium lacking glucose and glutamine (-Glc-Gln), 
all without serum. AMPK was isolated by immunoprecipitation (IP) and kinase activity 
determined. Results are mean ± SD, n = 4; asterisks show significant differences from 
control (+Glc+Gln); daggers (†) show significant differences between -Glc+Gln and -
Glc-Gln samples at the same time point. d, AMP:ATP ratios in an experiment as in c. 
Results are mean ± SD (n = 3); statistical significance as in c. e, g, as c, but using 
HEK293 cells expressing wild type (WT) FLAG-tagged AMPK-2 (e) or an 
AMP/ADP-insensitive R531G (RG) mutant9 (g). Results are mean ± SD, n = 4; 
statistical significance as in c. f, h, as d, but using HEK293 cells expressing WT or RG 
mutant. Results are mean ± SD, n = 3; statistical significance as in c. All experiments
were performed at least twice.
Figure 2 | Glucose starvation activates AMPK by a lysosomal mechanism 
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different from energy stress. a-b, Rapid effect of glucose removal on AMPK, but not 
the delayed effect of removal of glucose and glutamine, is dependent on AXIN and 
LAMTOR1. Experiments were performed in MEFs without serum as in Fig. 1c, except 
that cells carried homozygous floxed alleles of the AXIN (AXINF/F) (a) or LAMTOR1 
(LAMTOR1F/F) (b) genes. Prior to the experiment (36 h), MEFs were pre-treated with 
adenoviral vector expressing either Cre recombinase or empty vector. Samples were 
taken for AMPK assay; results in the top panels are mean ± SD, n = 4. The lower 
panels show western blotting of cell lysates using the indicated antibodies. c, 
Endogenous AMPK2 was knocked out in HEK293 cells by CRISPR-Cas9, and WT 
2, or G2A or S108A mutants, were re-expressed by transient transfection. Cells were 
then treated by removing glucose, or glucose plus glutamine, for 20 min as in a, or 
with 5 µM 991 or 300 µM berberine for 1 h, all without serum. AMPK2 complexes 
were immunoprecipitated and AMPK activity determined. Results are mean ± SD, n = 
4; asterisks or exact P values indicate means significantly different from controls (left-
hand columns) of the same genotype. d, Glucose starvation causes translocation of 
AMPK2 to the lysosome in HEK-293 cells that is dependent on N-myristoylation. 
The data are derived from the experiment shown in Extended Data Fig. 2f. Pearson 
correlations between red (lysosomes) and green (AMPK-2) stain across the 
cytoplasm were determined; results are for 7-9 cells under each condition, with 
horizontal bars representing mean ± SD. e, MEFs expressing WT LKB1 or a C433S 
knock-in13 were incubated ± glucose and/or glutamine for 20 min, or with DMSO, 
A769662 (300 µM) or berberine (300 µM) for 1 h, all without serum. Endogenous 
AMPK was immunoprecipitated and assayed (top) or lysates were analysed by 
Western blotting using the indicated antibodies (bottom). Results in the top panel are 
16
mean ± SD, n = 4; asterisks or exact P values show results significantly different from 
controls in full medium (removal of glucose and/or glutamine) or DMSO controls 
(A769662 and berberine). All experiments were performed at least twice.
Figure 3 | Absence of fructose-1,6-bisphosphate (FBP) defines a starvation signal 
for AMPK activation. All intact cell experiments in this Figure were performed in the 
presence of 10% serum. a, HEK293T cells were infected with lentivirus expressing
indicated siRNAs; the cells were then starved for glucose for 2 h, followed by analysis 
of p-AMPK and p-ACC levels. b, Cytosol from unstarved MEFs was mixed with
light organelles purified from glucose-starved MEFs. Various glycolytic intermediates 
(200 M) as indicated were individually added to the mixture. The mixtures were then
dissolved and LAMTOR1 was immunoprecipitated. c, FBP at physiologically relevant
concentrations completely dissociates AXIN/LKB1 from LAMTOR1. d, FBP (10 μM) 
was added to the 2-h-glucose-starved MEFs pre-incubated with streptolysin O (SLO)
for 5 min. After incubating for another 15 min, cells were lysed and were analyzed by 
immunoblotting. Experiments in a, b and d were performed 3 times, and the 
experiments in c twice.
Figure 4 | Aldolase is the receptor for FBP physically linking glucose deprivation 
to AMPK activation. All intact cell experiments in this Figure were performed in the 
presence of 10% serum. a, b, ALDO-TKD MEFs were generated from WT MEFs (a) 
or AXIN-/- MEFs (b) following the procedures depicted in Extended Data Fig. 6a. The 
cells were then incubated in the DMEM medium with or without glucose for 2 h, 
followed by analysis of p-AMPK and p-ACC levels. c, d, Activation of AMPK in 
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HEK293T cells stably expressing ALDOA-D34S (c), or in ALDO-TKD MEFs stably 
expressing ALDOA-K230A (d) were analyzed as in a. The experiment in a was 
performed 4 times, that in b and d twice, and that in c 3 times.
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METHODS
Data reporting. No statistical methods were used to predetermine sample size. The 
experiments were not randomized. The investigators were not blinded to group 
allocation and outcome assessment.
Mouse studies. AXINF/F, LAMTOR1F/F mice were generated and maintained as 
described6. LKB1F/F mice were obtained from Frederick National Laboratory for 
Cancer Research provided by Dr. Ron DePinho. CaMKK2-/- mice were obtained from 
The Jackson Laboratory, provided by Dr. Talal Chatila. Male C57BL/6J littermate
mice of 6-week old were used in this study. Mice were housed with free access to 
water and standard diet (65% carbohydrate, 11% fat, 24% protein). The light was on 
from 8 a.m. to 8 p.m. Adenovirus was propagated in AD293 (Adeno-X 293) cells and 
purified by cesium chloride density gradient ultracentrifugation. Adenoviruses (1.3 ×
109 plaque-forming units) were injected via the tail vein five days before analysis. For 
starvation, the diet was withdrawn from the cage at 5 p.m. and mice were sacrificed at 
9 a.m. the next day by cervical dislocation. Unless stated otherwise, liver tissues were 
dissected and instantly frozen in liquid nitrogen for further use. Protocols for all animal 
experiments were approved by the Institutional Animal Care and the Animal 
Committee of Xiamen University.
Plasmids. Point mutations of ALDOA were performed by a PCR-based site-directed 
mutagenesis method using PrimeSTAR HS polymerase (Takara). Expression plasmids 
for various proteins were constructed in the pCDNA3.3 vector for transient 
transfection, in pBOBI for lentivirus packaging (stably expression), or in pLVX-IRES 
for doxycycline-inducible expression. PCR products were verified by sequencing
(Invitrogen, China). The lentivirus-based vector pLL3.7 was used for expression of
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siRNA in HEK293T and MEFs. The 19-nucleotide sequence for each siRNA is as 
follows: 5’-CCAAGTGGCGCTGTGTGCT-3’ (#1) and 5’-GCCATGGGCCTT
GACTTTC-3’ (#2) for mouse ALDOA, 5’-GCTCTCTGAGCAGATCCAT-3’ (#1) 
and 5’-GGCAGTTCCGAGAACTCCT-3’ (#2) for mouse ALDOB, 5’-
GAGTCTAGAGC TTATGTCT-3’ (#1) and 5’-CAGTTACCCTTGATGGTAT-3’
(#2) for mouse ALDOC, 5’-GGGACATCAAACCTTCCAA-3’ for mouse CaMKK2, 
5’-GATGAAAGGGAAG
CTGGCA -3’ for mouse TPI,  5’-CCGAGAACACCGAGGAGAA-3’ for human 
ALDOA, 5’- CCAAAGCCCTGGAAACTAA -3’ for human ALDOB, and 5’-
CCTCAAACGTTGTCAGTAT -3’ for human ALDOC. The siRNAs against human
HK1, HK2, PFKM, PFKL, PFKP, G6PD (#1) and PHGDH (#1) were constructed and 
validated as described previously26. The siRNA against mouse GAPDH was 
constructed as described previously27. Human ALDOA and ALDOA-D34S were
constructed in pAdEasy-1 (Stratagene) for adenovirus packaging. Sequences of all 
oligonucleotides used in this study are available upon request.
CRISPR knockout of AMPK-1 and 2. The genes (PRKAB1 and PRKAB2) were 
deleted from HEK293 cells using the CRISPR-Cas9 system28. Targeting nucleotides 
for 1 were caccGTGAGCGCGCCGCGCTGGAG (a.a. 6-13) and caccGTGGCC
ATAAGACGCCCCGG (a.a. 15-22) and for 2 were caccGCCAAGGCTGCACG
CTCCGA (a.a. 15-27) and caccGTCGCTGGTGGTGTTTCCCA, (a.a. 1-7). 
Nucleotides were annealed to their complements containing the cloning tag aaac, and 
inserted into the back-to-back BbsI restriction sites of pSpCas9(BB)-2A-Puro 
(PX459) and pSpCas9(BB)-2A-GFP (PX458) (Addgene plasmids #48139 and 
#48138). Cells were transfected with a 1:1 mixture of GFP and Puro constructs 
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containing the CRISPR oligonucleotides, using 2-3 µg DNA in Fugene 6 transfection 
reagent per well of a 6 well plate. After 24 h, transfection was verified by fluorescence 
microscopy and cells trypsinised from the plates and re-plated into 15 cm dishes in the 
presence of puromycin (0.6 µg/ml). After 24 h the medium was changed, fresh 
puromycin added and cells grown for a further 48 h, at which time cells were 
transferred to medium without puromycin and allowed to grow until colonies formed. 
Colonies (20-30) were picked and expanded until large enough to allow freezing of 
stocks and analysis of AMPK-2 expression by Western blot and immunoprecipitate 
kinase assay. 
Reagents. Rabbit polyclonal antibody against LAMTOR1 was raised and 
validated as described previously
6
, and was diluted 1:100 for 
immunoprecipitation (IP) or 1:500 for immunoblotting (IB). Rabbit polyclonal 
antibody against PFKM was raised and validated as described previously
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and was diluted 1:500 for IB. Rabbit anti-phospho-AMPK-T172 (cat. #2535, 
1:1000 for IB), anti-AMPK (cat. #2532, 1:1000 for IB), anti-phospho-ACC-
Ser79 (cat. #3661, 1:1000 for IB), anti-ACC (cat. #3662, 1:1000 for IB), anti-
LKB1 (cat. #3047, 1:1000 for IB), anti-AXIN1 (cat. #2074, 1:1000 for IB), anti-
HK1 (cat. #2024, 1:1000 for IB), anti-HK2 (cat. #2867, 1:1500 for IB), anti-
PFKP (cat. #8164, 1:1000 for IB), anti-PFKL (cat. #8175, 1:1000 for IB), anti-
G6PD (cat. #12263, 1:1000 for IB), anti-PKM1/2 (cat. #3190, 1:1000 for IB), 
anti-ALDOA (cat. # 8060, 1:2000 for IB), anti--tubulin (cat. #2128, 1:1000 for 
IB), anti-AMPK1 (cat. #12063), anti-AMPK2 (cat. #4148), anti-HIS (cat. 
#12698, 1:500 for IB), and HRP-conjugated mouse anti-rabbit IgG
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(conformation specific, cat. #5127, 1:2000 for IB) antibodies were purchased 
from Cell Signaling Technology. In Figs. 1, 2 and Extended Data Fig. 1f, total 
ACC was detected using IR dye 800 conjugated streptavidin (Rockland, cat. 
#S000-32). Rabbit anti-ALDOB (cat. 18065-1-AP, 1:1000 for IB) and anti-
CaMKK2 (cat. 11549-1-AP, 1:500 for IB) antibodies were purchased from 
Proteintech. Mouse anti-ALDOC (cat. AM2215b, 1:2000 for IB) antibody was 
purchased from Abgent. Rabbit anti-PKLR (cat. ab38240, 1:500 for IB), rat 
anti-LAMP2 (cat. ab13524; 1:120 for IF), mouse anti-LAMP1 [cat. ab25630, 
1:120 for immunofluorescent staining (IF)], mouse anti-aldolase (cat. 
ab54770, 1:50 for IP), and goat anti-TPI (cat. ab28760, 1:1000 for IB) 
antibodies were purchased from Abcam. Mouse anti-PHGDH (cat. 
AMAB90786, 1:1000 for IB) and rabbit anti-GAPDH (cat. G9545, 1:1000 for 
IB) antibodies were purchased from Sigma. Goat anti-AXIN (cat. sc-8567, 
1:100 for IP and 1:60 for IF), mouse anti-HA (cat. sc-7392, 1:2000 for IB), anti-
LKB1 (cat. sc-32245, 1:100 for IP), and anti-goat IgG-HRP (cat. sc-2354, 
1:5000 for IB) antibodies were purchased from Santa Cruz Biotechnology.
The HRP-conjugated goat anti-mouse IgG (cat. 115-035-003, 1:5000 for IB) 
and HRP-conjugated goat anti-rabbit IgG (cat. 111-035-003, 1:5000 for IB) 
antibodies were purchased from Jackson ImmunoResearch. Glucose (cat. 
G7021), G3P (cat. G5251), DHAP (cat. D7137), 3PG (cat. P8877), 2PG (cat. 
19710), PEP (cat. P7002), N-acetylglucosamine (cat. A3286), octyl β-D-
glucopyranoside (ODG, cat. O8001) and SLO (cat. S5265) were purchased 
from Sigma. G6P (cat. sc-210728), F6P (cat. sc-202563) and FBP (cat. sc-
214805) were purchased from Santa Cruz Biotechnology. BPG was customized 
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from Triveni Interchem Pvt Ltd. GlutamaxTM (cat. 35050) and sodium pyruvate 
(cat. 11360) was purchased from Gibco. Doxycycline (cat. S4163) was 
purchased from Selleckchem. Protease inhibitor cocktail was purchased from 
Roche (cat. 04693116001). [U-13C]glucose (cat. CLM-1396-PK) and [U-13C]FBP
(cat. CLM-8962-0) were purchased from Cambridge isotope laboratories. Full names 
for glycolytic intermediates: Glc, glucose; G6P, glucose-6-phosphate; F6P, fructose-6-
phosphate; G3P, glyceraldehyde-3-phosphate; DHAP, dihydroxyacetone phosphate; 
BPG, 1,3-bisphosphoglycerate; 3PG, 3-phosphoglycerate; 2PG, 2-phosphoglycerate;
PEP, phosphoenolpyruvate; Pyr, pyruvate.
Cell culture, transient transfection and lentivirus infection. HEK293T, HEK293, 
AD293 cells and MEFs were maintained in Dulbecco’ s modified Eagle’ s medium 
(DMEM, Gibco, cat. 11965) supplemented with 10% fetal bovine serum (FBS), 100 
IU penicillin, 100 mg/ml streptomycin at 37 °C in a humidified incubator containing 
5% CO2. Polyethylenimine (Polysciences, Inc., Cat. #23966) at a final concentration of 
10 M was used to transfect HEK293T cells. Total DNA for each plate was adjusted 
to the same amount by using relevant empty vector. Transfected cells were harvested 
at 24 h after transfection. Lentivirus for infection of the MEFs was packaged in 
HEK293T cells using Lipofectamine 2000 (Invitrogen, Cat. 11668-027) transfection. 
At 30 h post transfection, medium was collected and added to the cells. The cells were 
incubated for another 24 h. LAMTOR1F/F, AXINF/F, LKB1F/F or CaMKK2-/- MEFs were 
established by introducing SV40 T antigen into primary cultured embryonic cells from 
a litter of corresponding mice. LAMTOR1-/-, AXIN-/- or LKB1-/- MEFs were generated 
by infecting LAMTOR1F/F, AXINF/F or LKB1F/F MEFs with adenoviruses expressing Cre 
recombinase for 12 h. The infected cells were then incubated in the fresh DMEM for 
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another 8 to 10 h before further treatments. HEK293T cells were obtained from 
ATCC. HEK293 cells were obtained from Invitrogen. AD293 cells were obtained from 
Clontech. Cells were verified to be free of mycoplasma contamination and 
authenticated by STR sequencing. For starvation, cells were rinsed twice with PBS, 
and then incubated in glucose-free DMEM (Gibco, cat. 11966) supplemented with 
10% FBS and 1 mM sodium pyruvate (Gibco, cat. 11360) for desired periods of time 
at 37 °C. For starvation for glucose plus glutamine, cells were incubated in DMEM 
without glucose, glutamine, phenol red or pyruvate (Gibco cat. A14430-01) with the 
addition of 1 mM pyruvate (Lonza cat. BE 13-11 SE) with or without Glutamax™
(Gibco cat. 35050-038) and D-glucose (Gibco cat. A2494001). For determining the 
effect of different glycolytic intermediates on affecting AMPK activation in cells, the 
cells were first permeabilized with SLO as described previously29 (incubated with SLO 
for 5 min). After incubating for another 15 min, cells were lysed and were analyzed by 
immunoblotting.
Immunoprecipitation and immunoblotting. IP was carried out as described 
previously6. Briefly, 10 × 15 cm dishes of MEFs (grown to 80% confluence) for
immunoprecipitating LAMTOR1 or 4 × 15 cm dishes of MEFs (grown to 80%
confluence) for immunoprecipitating AXIN in each lane were collected and lysed with 
750 l/dish of ice cold ODG buffer (50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 1 mM 
EDTA, 1 mM EGTA, 2% ODG, 5 mM -mercaptoethanol with protease inhibitor 
cocktail). Cell lysates were incubated with respective antibodies overnight. Overnight 
protein aggregates were pre-cleared by centrifugation at 20,000g for 10 min, and 
protein A/G beads (1:100 for immunoprecipitating AXIN and 1:250 for LAMTOR1) 
were then added into the lysates and mixed for another 3 h. The beads were washed 
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with 100 times volume of ODG buffer for 3 times at 4 °C and then mixed with an equal 
volume of 2× SDS sample buffer for immunoblotting. To analyze the levels of p-
AMPK and p-ACC in MEFs, cells grown to 70-80% confluence in a well of a 6-well 
dish were lysed with 250 l of ice cold lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 
1 mM -glycerolphosphate, with protease inhibitor cocktail). The lysates were then 
centrifuged at 20,000g for 10 min at 4 °C and an equal amount of 2× SDS sample 
buffer was into the supernatant. The levels of p-AMPK and p-ACC were then 
analyzed by immunoblotting. To analyze the levels of p-AMPK and p-ACC in liver, 
the freshly excised liver tissues were added with ice cold lysis buffer (10 l/mg liver 
weight), followed by homogenization and centrifugation as described above. The 
lysates were then mixed with 2× SDS sample buffer and then subjected to 
immunoblotting. Levels of total proteins and the levels of phosphorylation of proteins 
were analyzed on separate gels. The band intensities on developed films were 
quantified using Image J software (National Institutes of Health Freeware).
Fluorescence microscopy. Cells were grown on glass coverslips in 6-well dishes and 
were cultured to 60-80% confluence. Cells were fixed with 1 ml of 4% formaldehyde 
(diluted in PBS) at room temperature for 20 min. They were rinsed 2x with 1 ml of 
PBS (room temperature) and then permeabilized with 1 ml of 0.1% Triton X-100 
(diluted in PBS) for 5 min at 4 °C. Cells were rinsed 2x with 1 ml of PBS, and were 
incubated with primary antibodies overnight at 4 °C. The cells were then rinsed 3x 
with 1 ml of PBS, and then incubated with Alexa-Fluor 488-conjugated anti-goat 
secondary antibody (Molecular Probes, A11058; diluted 1:100 in PBS) and Alexa-
Fluor 594-conjugated anti-rat secondary antibody (Molecular Probes, cat. A21209; 
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diluted 1:100 in PBS)/Alexa-Fluor 594-conjugated anti-mouse secondary antibody 
(Molecular Probes, cat. A11032; diluted 1:100 in PBS) for 8 h at room temp in the 
dark. They were washed for 4 times with 1 ml of PBS, and then mounted on slides by 
ProLong Diamond Antifade Mountant (Molecular Probes, cat. P36970). Cells were 
imaged under a Zeiss LSM 780. Samples were excited with Ar gas laser (Zeiss, laser 
module LGK 7812) using a 488-nm laser line for Alexa-Fluor 488 dye (green channel), 
and with HeNe gas laser (Zeiss, LGK 7512 PF) using a 594-nm laser line for Alexa-
Fluor 594 dye (red channel). Confocal microscope pictures were taken with a 63× oil 
objective. The parameters, including PMT voltage, Offset, Pinhole and Gain were kept 
unchanged between each picture taken. For quantitative analyses in Fig. 2d, Pearson’s
correlations were performed using Volocity 5.2 software, analyzing the whole cell but 
excluding the nucleus. For quantitative analyses in Extended Data Fig. 7a and 7b,
colocalization percentages (determined by Mander’s overlap coefficient-the number of 
pixels from the red channel that overlap with pixels from the green channel divided by 
the total number of pixels detected in the red channel above the threshold value) were 
calculated by ZEN 2010 software (Zeiss). Thresholds were set automatically by the 
software using the method of Costes et al (2004)30.
AMPK assays. AMPK was assayed using the AMARA peptide as substrate in 
resuspended immunoprecipitates made using a equal mixture of anti-AMPK1 and -
AMPK2 antibodies9, except for the assays in Fig 2c and Extended Data Fig. 2e where 
we immunoprecipitated using anti-AMPK2 and AMPK1 antibodies respectively, 
and Fig. 1g and 1i where we immunoprecipitated using anti-FLAG antibodies.
Aldolase assays. Aldolase enzymatic assay was performed as described previously31, in 
which 3-phosphoglyceraldehyde reacts with hydrazine to form hydrazone that absorbs 
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at 240 nm. Briefly, MEFs (80% confluence grown in a 10-cm dish) were collected,
washed with PBS, and lysed with 500 μl of digitonin solution (100 μg/ml PBS). Some 
5 μl of cell lysate was incubated with EDTA (0.1 mM final concentration), iodoacetate
(0.2 mM final concentration) and hydrazine (2.33 mM final concentration), and the 
digitonin solution was added to make a final volume of 300 μl. A blank read was taken 
at 240 nm. FBP (5 mM final concentration) were added and the OD240 was determined 
in 1 min intervals by a SpectraMax M5 microplate reader (Molecular Device).
Enzymatic activity was determined in triplicate and normalized to the control.
In vitro reconstitution for lysosomal binding assays. The assays were 
performed as described previously
6
. Full length His-tagged AXIN was 
expressed and purified as described previously
7
. In general, each 
reconstitution reaction requires light organelles from two 15-cm dishes of 
MEFs and cytosol from four 15-cm dishes. Cells were scraped and spun down at 
200g at room temperature, and then resuspended in 750 l per 15-cm dish of 
fractionation buffer [50 mM KCl, 90 mM K-Gluconate, 1 mM EGTA, 5 mM MgCl2, 
50 mM sucrose, 20 mM HEPES, pH 7.4, supplemented with 2.5 mM ATP, amino 
acids (Gibco, cat. 11130-077) and protease inhibitor cocktail] at room temperature,
and were mechanically broken by spraying 6 times through a 22G needle, then yielding 
a post-nuclear supernatant (PNS) by spun at 2,000g for 5 min. The PNS was then spun 
at max speed for 15 min in a tabletop centrifuge. The light organelles (the pellets) were 
thus separated from the cytosol (the supernatants). Light organelles were then re-
suspended with 100 l of fractionation buffer containing glycolytic intermediates as 
indicated and were incubated at 37 °C, in the thermomixer at 400 r.p.m. for 15 
min. Some 500 l of cytosol or 1 g of His-AXIN was then added to the mixture, 
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followed by incubation at 37 °C for another 25 min. The mixtures were lysed with 
800 l of ODG buffer, followed by IP with antibody against LAMTOR1.
CE-MS-based analysis of metabolites. Sample preparation for CE (capillary 
electrophoresis)-MS was carried out as described previously32,33, with some 
modifications. In general, each measurement requires cells collected from a 10-cm dish 
(60-70% confluence) or 100 mg of liver tissue. For analysis of metabolites, cells were 
rinsed with 20 ml of 5% mannitol solution (dissolved in water) and instantly frozen in 
liquid nitrogen. Cells were then lysed with 1 ml of methanol containing internal 
standards 1 [IS1 (Human Metabolome Technologies, H3304-1002, 1:200), used to 
standardize the metabolite intensity and to adjust the migration time], and were 
scrapped off from the dish. For analysis of metabolites in liver, the fleshly excised 
tissue was freeze-clamped first, then washed in pre-cooled 5% mannitol solution and 
grinded in 1 ml of methanol with 50 M IS1. The lysate was then mixed with 1 ml of 
chloroform and 400 l of water by 20 s of vortexing. After centrifugation at 
15,000g for 15 min at 4 °C, 450 l of aqueous phase was collected and was then 
filtrated through a 5 kDa cutoff filter (Millipore, cat. UFC3LCCNB-HMT) by 
centrifuging at 10,000g for 3 h at 4 °C. Simultaneously, the quality control (QC) 
sample was prepared by combining 100 l of the aqueous phase from each samples and 
then filtered. The filtered aqueous phase was then freeze-dried in a vacuum 
concentrator and then dissolved in water containing internal standards 3 [IS3 (Human 
Metabolome Technologies, H3304-1104, 1:200), to adjust the migration time]. 20 l
of re-dissolved solution was then loaded into an injection vial with a conical insert for 
CE-TOF MS (Agilent Technologies 7100, equipped with 6224 mass spectrometer) 
analysis. Instrumental analysis and data processing were performed as described 
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previously. For quantifying absolute concentrations of FBP, [U-13C]FBP (10 g/mL) 
was used as internal standard. A standard curve and a two parameter polynomial 
equation were generated by plotting the ratios of unlabeled FBP:labelled FBP (peak 
area:peak area) against the concentrations of unlabeled FBP. The amount of FBP was 
then estimated according to the equation. The total concentrations of FBP in mouse 
liver ([FBP]liver) were obtained by dividing the values of the amount of FBP by the 
estimated volume of liver. The concentrations of free-state FBP were then estimated, 
according to the value of [FBP]liver, as described previously.
ATP, ADP and AMP detection by LC-MS. The three compounds (ATP, ADP and 
AMP) levels were measured using a TSQ Quantiva interfaced with Ultimate 3000 
Liquid Chromatography system (ThermoScientific), equipped with a porous graphitic 
carbon column (HyperCarb 30x1mm ID 3 μm; Part No: C-35003-031030, Thermo-
Scientific). Mobile phase buffer A consisted of 0.3% (v/v) formic acid adjusted to pH 9 
with ammonia prior to a 1/10 dilution. Mobile phase buffer B was 80% (v/v) 
acetonitrile. The column was maintained at a controlled temperature of 30C and was 
equilibrated with 10% buffer B for 5 minutes at a constant flow rate of 0.06 mL/min. 
Aliquots of 1 µL of each sample were loaded onto the column and compounds were 
eluted from the column with a linear gradient of 10%-60% buffer B over 9 min. Buffer 
B was then increased to 100% within 1 min, and the column was washed for a 5 min 
with 100% Buffer B. Eluents were sprayed into the TSQ Quantiva using Ion Max NG 
ion source with ion transfer tube temperature set to 350C and vaporizer temperature 
125C. The TSQ Quantiva was run in negative mode with a spray voltage of 2600, 
sheath gas 40 and Aux gas 10. Levels of ATP, ADP and AMP were measured using 
multiple reactions monitoring mode (MRM) with optimised collision energies and 
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radio frequencies previously determined by infusing pure compounds. Three transitions 
were used to monitor each of the three compounds, ATP (505.92>158.98, 
505.92>408.12 and 505.92>426.12), ADP (426.98>158.98, 426.98>328.78 and 
426.98>409.09) and AMP (345.96>134.20, 345.96>151.27 and 345.96>211.12).
Statistical analysis. For experiments in Fig. 1 and 2 and Extended Data Fig. 1 and 2, 
1-way or 2-way ANOVA was performed with Holm-Sidak’s multiple comparison test 
(by GraphPad Prism 6 for MacOS), unless specified otherwise. For all other 
experiments, 1-way or 2-way ANOVA with post hoc analysis was used to compare 
values among different experimental groups. For experiments with only two groups, a 
two-tailed Student’s t test was used as specified in the figure legends. For ANOVA, 
the homogeneity of variance was tested by Levene’s test. If the results are similar, the 
Tukey's test was preceded, and if not, the Games-Howell’s test was preceded. Similar 
procedures were followed when Student's t test was performed. No samples or animals 
were excluded from the analysis. Tests were performed with SPSS Statistics 17.0 
program, and P < 0.05 was considered statistically significant. Where exact P values 
are not shown, statistical significance is shown as */† P < 0.05, **/†† P < 0.01, ***/†††
P < 0.001, ****/†††† P < 0.0001.
Data availability. The authors declare that all data supporting the findings of this
study are available within the paper and the Supplementary Information files.
Li, T. Y. et al. ULK1/2 Constitute a Bifurcate Node Controlling Glucose 26.
Metabolic Fluxes in Addition to Autophagy. Molecular cell 62, 359-370, 
doi:10.1016/j.molcel.2016.04.009 (2016).
30
Alvarez-Erviti, L. et al. Delivery of siRNA to the mouse brain by systemic 27.
injection of targeted exosomes. Nature biotechnology 29, 341-345, 
doi:10.1038/nbt.1807 (2011).
Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. 28.
Protoc. 8, 2281-2308, doi:10.1038/nprot.2013.143 (2013).
Kao, A. W., Noda, Y., Johnson, J. H., Pessin, J. E. & Saltiel, A. R. Aldolase 29.
mediates the association of F-actin with the insulin-responsive glucose transporter 
GLUT4. The Journal of biological chemistry 274, 17742-17747 (1999).
Costes, S. V. et al. Automatic and quantitative measurement of protein-protein 30.
colocalization in live cells. Biophys. J. 86, 3993-4003, 
doi:10.1529/biophysj.103.038422 (2004).
Hu, H. et al. Phosphoinositide 3-Kinase Regulates Glycolysis through 31.
Mobilization of Aldolase from the Actin Cytoskeleton. Cell 164, 433-446, 
doi:10.1016/j.cell.2015.12.042 (2016).
Zhao, J. et al. Study of polar metabolites in tobacco from different geographical 32.
origins by using capillary electrophoresis–mass spectrometry. Metabolomics 10, 
doi:10.1007/s11306-014-0631-4 (2014).
Zhao, Y. et al. A metabolomics study delineating geographical location-associated 33.
primary metabolic changes in the leaves of growing tobacco plants by GC-MS and 
CE-MS. Scientific reports 5, 16346, doi:10.1038/srep16346 (2015).
Dennis, J. W., Nabi, I. R. & Demetriou, M. Metabolism, cell surface organization, 34.
and disease. Cell 139, 1229-1241, doi:10.1016/j.cell.2009.12.008 (2009).
Sols, A. & Marco, R. in Current Topics in Cellular Regulation Vol. Volume 2 35.
(eds L. Horecker Bernard & R. Stadtman Earl) 227-273 (Academic Press, 1970).
31
Legends for Extended Data Figures
Extended Data Figure 1 | Glucose deprivation activates AMPK via an AMP/ADP 
independent mechanism. a, Phosphorylation of AMPK (pT172) and ACC (pACC) 
analyzed by immunoblotting from the experiment shown in Fig. 1a; the upper panel 
shows quantification of the pT172:AMPK ratios (mean ± SD, n = 2). b-c, Glucose 
deprivation rapidly activates AMPK without altering cellular AMP:ATP or ADP:ATP 
ratios in HEK293T cells. Cells were grown in full medium (25 mM glucose, 4 mM 
alanyl-glutamine, 1 mM pyruvate, 10% serum) and then switched to medium without 
glucose, with other components unchanged, for 15 min or 2 h. AMPK activation was 
monitored by immunoblotting for p-AMPKα and p-ACC (a), and intracellular 
AMP:ATP/ADP:ATP ratios determined by CE:MS (b, results are mean ± SD, n = 3). 
d, Adenine nucleotide ratios are unaltered in mouse liver after starvation. Mice were 
fed ad libitum or fasted for 16 h, freeze-clamped liver samples prepared, and 
AMP:ATP/ADP:ATP ratios measured by CE-MS. Results are mean ± SD, n = 6; ns, 
not significant by Student’s t-test. e, Decrease in plasma glucose concentrations 
induced by fasting mice for 16 h. Mice from the same experiment shown in Fig. 1d 
were either fed ad libitum or were deprived of food for 16 h and plasma glucose 
determined. Circles are individual data points and horizontal lines are means ± SD, n = 
6; P value computed by Student’s t test. f, Extracts were prepared from livers of mice 
treated as in d (6 mice per group) and analysed by Western blotting using the indicated 
antibodies. g, Western blots from the same experiment shown in Fig. 1c. Although 
shown as separate panels, the blots with each antibody were from the same gel scanned 
at the same time, and are therefore directly comparable. h, quantification of blots in g. 
Results are mean ± SD, n = 2. i, ADP:ATP ratios determined by LC:MS, from the 
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same experiments shown in Fig. 1c and d. j, Time course of effects of starving MEFs
for glucose only, or glucose and glutamine, in the presence of serum. The experiment 
was as in Fig. 1c except that the medium contained 10% fetal calf serum throughout.
k, l, ADP:ATP ratios determined by LC:MS, from the experiments shown in Figs. 1e-
h. All experiments were performed at least twice.
Extended Data Figure 2 | Glucose deprivation activates AMPK by a mechanism 
distinct from energy stress. a, b, d, AXIN-/- (a), LAMTOR1-/- (b) and CaMKK2 
knockdown (d) MEFs were incubated with DMEM containing indicated 
concentrations of glucose for 2 h. The levels of p-AMPK and p-ACC in the cell 
lysates were analyzed by immunoblotting. c, AMP:ATP and ADP:ATP ratios in AXIN-/-
and LAMTOR1-/- MEFs, generated as in Fig. 2a, b. e, Validation of monoclonal anti-2 
antibody for use in immunofluorescence microscopy. Parental wild type HEK293 cells, 
or 2 KO cells, were stained with DAPI (blue, nuclei) and anti-2 antibody (green). 
Representative merged images are shown, obtained using identical intensity settings. f, 
Glucose starvation causes translocation of AMPK2 to the lysosome in HEK-293 cells 
that is dependent on N-myristoylation. The experiment was performed in 2 KO cells 
as in Fig. 1c, except that the lysosomal marker LAMP1 (tagged with RFP) was co-
expressed with the WT or AMPK-2 mutants. Upper panels show merged images 
stained blue [4',6-diamidino-2-phenylindole (DAPI), nuclei], red (LAMP1, lysosomes) 
and green (AMPK-2, detected using antibody validated in Extended Data Fig. 2e), in 
cells incubated with or without glucose for 20 min. Lower small panels are 
magnifications of the areas indicated by dashed boxes in the upper panels, showing (L 
to R) red and green channels and merged images. g, Experiment identical to that 
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shown in Fig. 2c, but expressing AMPK-1, either WT, G2A or S108A mutants, in 1 
KO cells. Results are mean ± SD, n = 4. All experiments were performed at least 
twice.
Extended Data Figure 3 | Glycolytic intermediate(s) is responsible for repression 
of AMPK in the presence of glucose. All intact cell experiments in this Figure were 
performed in the presence of 10% serum. a, Summary of glycolysis pathway and 
pathways branching off it. PPP, pentose phosphate pathway; SSP, serine synthesis 
pathway; HP, hexosamine pathway. b, c, Knockdown of G6PD (glucose-6-phosphate 
dehydrogenase) (b) or PHGDH (phosphoglycerate dehydrogenase) (c) has no effect 
on AMPK activation. HEK293T cells were infected with lentivirus expressing siRNA 
against G6PD (b) or PHGDH (c), or siRNA against GFP as a control; the cells were 
then incubated in the DMEM medium with (25 mM) or without glucose for 2 h, 
followed by analysis of p-AMPKα and p-ACC levels. d, The hexosamine pathway is 
not involved in AMPK regulation under glucose deprivation. MEFs were incubated for 
2 h in the DMEM medium containing GlcNAc (N-acetylglucosamine), an supplement 
of hexosamine pathway which cannot be converted back to glucose34, at indicated 
concentrations and 25 mM or 0 mM glucose. Cells were then subjected to 
immunoblotting. Experiments in b and c were performed twice, and that in d 3 times.
Extended Data Figure 4 | Absence of fructose-1,6-bisphosphate (FBP) defines a 
starvation signal for AMPK activation. All intact cell experiments in this Figure 
were performed in the presence of 10% serum. a, FBP dissociates AXIN/LKB1 from 
LAMTOR1 in vitro. The same experiment identical to that in Fig. 3b was performed 
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except that the bacterially expressed His-tagged AXIN was used in lieu of AXIN-
containing cytosol, incubating with light organelles purified from MEFs glucose-
starved for 2 h. b, FBP modulates the interaction between AMPK and LKB1. Cytosol 
from unstarved MEFs was mixed with light organelles purified from 2-h-glucose-
starved ALDO-TKD MEFs or WT MEFs, followed by addition of 200 M FBP. The 
mixtures were then dissolved and LKB1 was immunoprecipitated. c, Concentrations of 
FBP in mouse liver after starvation for 16 h. FBP levels from mouse livers were 
determined by CE-MS. The amounts of FBP were estimated according to the standard 
curve generated by plotting the peak-area ratios of unlabeled:13C-labelled FBP (derived 
from [U-13C]FBP used as internal standard) against the concentrations of unlabeled 
FBP. The results were obtained by dividing its amount by the estimated volume of 
liver, and the concentrations of free-state FBP were then estimated as described 
previously35. Values are presented as mean ± SEM, n = 5 for each condition, P = 9.627 
× 10-5 (Student’s t-test). d, e, Intracellular FBP levels were measured by CE-MS in 
MEFs after incubation in medium containing different concentrations of glucose (d), or 
in glucose-free DMEM for the indicated time periods (e). Values are presented as 
mean ± SD, n = 3 for each treatment; *P = 0.0187, FBP levels in cells incubated in 10 
mM glucose were compared to those in cells incubated with medium containing 5 mM 
glucose; †P = 0.0102, cells incubated with medium containing 5 mM to 3 mM glucose; 
P = 0.831, cells incubated with medium containing 25 mM to 10 mM glucose; P = 
0.00577, comparison of incubation in glucose-free medium for 0 min to 15 min 
(ANOVA). f, Plasma glucose concentrations (left panel) and intracellular FBP levels 
(right panel) in mouse liver. FBP were determined by CE-MS analysis. Results are 
mean ± SD, n = 6 for each condition; P value by Student’s t-test. g, h, Linear 
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correlation between extracellular glucose concentrations and intracellular FBP levels. 
FBP levels in MEFs, measured at 2 h of incubation in medium containing various 
concentrations of glucose as shown in d, and in the starved mouse liver shown in f, 
were plotted against their corresponding glucose concentrations in the culture medium 
(g) and plasma (h), respectively. i, FBP levels in SLO-permeabilized MEFs. Levels of 
FBP in regularly cultured SLO-permeabilized MEFs (left panel), or glucose-starved 
SLO-permeabilized MEFs treated with exogenous FBP (right panel), were determined 
by CE-MS analysis. Results are mean ± SD, n = 3 for each condition; P value by 
Student’s t-test (left panel) and ANOVA (right panel). Experiments shown in left and 
right panels were performed simultaneously and shared a single control (SLO-
permeabilized MEFs incubated in medium containing 25 mM glucose). j-l, Addition of 
exogenous FBP to permeabilized MEFs blocks glucose starvation-induced AMPK 
activation. Various glycolytic intermediates (200 M) as indicated were individually 
added to the 2-h-glucose-starved WT (j), PFK1-KD (k) or TPI-KD (l) MEFs pre-
incubated with SLO for 5 min. After incubating for another 15 min, cells were lysed 
and were analyzed by immunoblotting. Experiments in this figure were performed 
twice.
Extended Data Figure 5 | Modulation of FBP controls AMPK activation. All 
intact cell experiments in this Figure were performed in the presence of 10% serum. a, 
Knockdown of PFK1 activates AMPK in unstarved cells. HEK293T cells were 
infected with lentivirus expressing PFKP, PFKL and PFKM siRNA, or GFP siRNA as 
a control, and were incubated in the DMEM medium with or without glucose for 2 h, 
followed by analysis of p-AMPKα and p-ACC levels. b, c, Effects of overexpression of 
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FBP1 and PFKP on AMPK activation. HEK293T cells were infected with lentivirus 
expressing FBP1 (b) or PFKP (c), and were then incubated in the DMEM medium 
with indicated glucose concentrations for 2 h, followed by analysis of p-AMPKα and p-
ACC levels. d, Knockdown of GAPDH has no effect on AMPK activation. MEFs 
were infected with lentivirus expressing GAPDH siRNA, or GFP siRNA as a control, 
and were glucose-starved for 2 h, followed by analysis of p-AMPKα and p-ACC 
levels. Experiments in this figure were performed twice.
Extended Data Figure 6 | Knockdown of aldolase renders AMPK activation 
constitutive. All intact cell experiments in this Figure were performed in the presence 
of 10% serum. a, Schematic diagram showing the strategy for knocking down the 
three aldolases (isozymes ALDOA-C) in MEFs. In detail, MEFs carrying doxycycline-
inducible expression of ALDOA-C were cultured in medium containing doxycycline 
(Dox, 100 ng/ml), and were infected with lentivirus expressing siRNA against ALDOA, 
ALDOB and ALDOC sequentially, or GFP siRNA as a control, followed by incubation 
in doxycycline-free medium for another 12 h. For Fig. 4a and 4b, #1 siRNAs targeting 
each enzyme were used. b, Validation of the efficiency and specificity of siRNAs 
targeting ALDOA-C in MEFs. Cell lysates from MEFs expressing siRNAs against 
ALDOA, ALDOB, ALDOC or GFP as a control (minus) were immunoblotted as 
indicated. c, Validation of aldolase-knockdown efficiency by measuring the activity of 
aldolase in ALDO-TKD cells. Aldolase activities in cell lysates prepared from ALDO-
TKD and WT MEFs were measured. Results are mean ± SD, n = 3; P value by 
ANOVA. d, Knockdown of the three aldolase isozymes renders AMPK activation 
constitutive. In an experiment identical to Fig. 4a for knocking down the aldolases, the 
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#2 siRNAs targeting each isozyme were used. e, Pyruvate kinase (PK) is not involved 
in regulation of AMPK. HEK293T cells were infected with lentivirus expressing PKM
and PKLR siRNA, or GFP siRNA as a control; the cells were then incubated in the 
DMEM medium with or without glucose for 2 h, followed by analysis of p-AMPK
and p-ACC levels. f, Knockdown of aldolase does not alter the energy status in MEFs. 
AMP:ATP/ADP:ATP ratios in WT and ALTO-TKD MEFs were measured by CE-
MS. Results are mean ± SD, n = 3; N.S., not significant by Student’s t-test. g-i, 
Aldolase regulates AMPK through the lysosomal pathway. Aldolases in LKB1-/- (g), 
LAMTOR1-/- (h) and CaMKK2-/- (i) MEFs were knocked down following the 
procedures described in a, and were incubated with DMEM medium with 25 mM 
glucose. The levels of p-AMPK and p-ACC in the cell lysates were analyzed by 
immunoblotting. j, Triple knockdown of aldolases promotes the formation of 
Ragulator-AXIN/LKB1-AMPK complex. Endogenous LAMTOR1 in regularly 
cultured or glucose-starved ALDO-TKD MEFs were immunoprecipitated, followed by 
immunoblotting. k, Knockdown of aldolase enhances the interaction between AMPK 
and LKB1. Experiment identical to that shown in j, but the endogenous LKB1 was 
immunoprecipitated. l, FBP fails to dissociate AXIN/LKB1 from LAMTOR1 on light 
organelles purified from starved ALDO-TKD MEFs. Cytosol from unstarved MEFs 
was mixed with light organelles purified from 2-h-glucose-starved ALDO-TKD MEFs 
or WT MEFs as a control, and 200 M FBP was then added to the mixture. The 
mixtures were then solubilized and LAMTOR1 was immunoprecipitated. m, Addition 
of exogenous FBP fails to block glucose starvation-induced AMPK activation in 
permeabilized ALDO-TKD MEFs. FBP (200 M) was added to the 2-h-glucose-
starved ALDO-TKD MEFs or WT MEFs that had been pre-incubated with SLO for 5 
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min. After incubating for another 15 min, cells were subjected to immunoblotting. n, 
FBP is the unique intermediate that modulates aldolase for sensing the availability of 
glucose. FBP, fructose-2,6-bisphosphate (F26P), and fructose-1-phosphate (F1P) at 
200 M were individually added to light organelles purified from 2-h-glucose-starved 
MEFs. The mixtures were then solubilized and LAMTOR1 was immunoprecipitated, 
followed by immunoblotting to determine co-precipitated proteins. Experiments in b, 
e, g-l were performed 3 times, and that in c, d, f, m and n twice.
Extended Data Figure 7 | AXIN is constitutively localized to lysosomes in aldolase-
deficient MEFs and HEK293T cells. All intact cell experiments in this Figure were 
performed in the presence of 10% serum. a, b, Immunofluorescent staining in WT and 
ALDO-TKD MEFs (a) and HEK293T cells (b) was performed. Rat anti-LAMP2 
antibody and goat anti-AXIN antibody were used for staining MEFs (a), and mouse 
anti-LAMP1 antibody and goat anti-AXIN antibody for HEK293T cells (b). The 
antibodies had been validated previously6. c, d, Mander’s overlap coefficients of a and 
b were graphed in c and d, respectively, as mean ± SD, n = 61 (siGFP, unstarved), 54 
(siGFP, GS), 60 (siALDOA-C, unstarved), 58 (siALDOA-C, GS) (c) and n = 57 
(siGFP, unstarved), 48 (siGFP, GS), 52 (siALDOA-C, unstarved), 51 (siALDOA-C, 
GS) (d) for each group; P value by ANOVA. N.S., not significant. The experiment 
was performed twice.
Extended Data Figure 8 | Effects of aldolase mutants on AMPK activation. All 
intact cell experiments in this Figure were performed in the presence of 10% serum. a, 
ALDOA-D34S mutant increases intracellular FBP levels under glucose starvation. 
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HEK293T cells stably expressing ALDOA or its D34S mutant were incubated in 
DMEM with or without glucose for 2 h, followed by measuring FBP levels. Results 
are mean ± SD, n = 3; P value by ANOVA. N.S., not significant. b, D34S mutant of 
ALDOA that still binds FBP in glucose-free medium exhibits reduced AMPK 
activation. ALDO-TKD MEFs stably expressing ALDOA-D34S, or wild type ALDOA 
as control, were incubated in DMEM medium with or without glucose for 2 h, 
followed by immunoblotting. c, ALDOA-D34S blunts the formation of Ragulator-
AXIN/LKB1-AMPK complex. HEK293T cells stably expressing ALDOA and 
ALDOA-D34S were lysed and the endogenous LAMTOR1 was immunoprecipitated, 
followed by immunoblotting. d, Adenovirus-mediated expression of the D34S mutant 
in mouse liver blocks AMPK activation after starvation. Adenovirus expressing 
ALDOA-D34S, or WT ALDOA as control, was injected into the tail veins of 6-week-
old mice. Five days later, mice were fasted for 16 h. Phosphorylation of AMPKα and 
ACC were then determined by immunoblotting. e, K230A mutant of aldolase promotes 
the formation of Ragulator-AXIN/LKB1-AMPK complex. Endogenous LAMTOR1 in 
unstarved or glucose-starved WT MEFs and ALDOA-K230A MEFs were 
immunoprecipitated, followed by immunoblotting. f, FBP fails to dissociate 
AXIN/LKB1 from LAMTOR1 on light organelles purified from starved ALDOA-
K230A MEFs. Cytosol from unstarved MEFs was mixed with light organelles purified 
from 2-h-glucose-starved ALDOA-K230A MEFs or WT MEFs as a control, and 200 
M FBP was then added to each mixture. The mixtures were then dissolved and 
LAMTOR1 was immunoprecipitated, followed by immunoblotting. g, Addition of 
exogenous FBP fails to block glucose starvation-induced AMPK activation in 
permeabilized ALDO-K230A expressed, TKD-MEFs (ALDOA-K230A MEFs). FBP 
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(200 M) was added to the 2-h-glucose-starved ALDOA-K230A MEFs or WT MEFs 
that had been pre-incubated with SLO for 5 min. After incubating for another 15 min, 
cells were subjected to immunoblotting. Experiments in c and f were performed 3 
times, and that in a, b, d, e and g twice.
Extended Data Figure 9 | FBP is predominantly derived from glucose. All intact 
cell experiments in this Figure were performed in the presence of 10% serum. a, 
Isotopomeric distribution of metabolites derived from D-[U-13C]glucose. 13C atoms are 
marked as filled circles. Note that FBP can be converted from various substrates 
besides glucose, but the conversion of glucose to F6P and then to FBP (grey-shaded 
area) is the only way that yields completely M+6 labelled FBP. b, c, MEFs (b) or 
HEK293T cells (c) were incubated in DMEM medium without glucose for 4 h. The 
medium was then added with 25 mM D-[U-13C]glucose. After 15 min or 4 h of 
incubation, the labeled FBP levels in cells were measured by CE-MS. The results 
shown that FBP produced after re-addition of glucose to the MEFs was almost entirely 
M+6 labelled. The experiment was performed twice.
Extended Data Figure 10 | Aldolase interacts with the v-ATPase-Ragulator 
complex. a, A simplified model depicting that aldolase is a sensor of glucose 
availability that directly links glucose shortage to activation of AMPK. b, HEK293T 
cells were lysed and the endogenous aldolase was immunoprecipitated, followed by 
immunoblotting. The experiment was performed twice.
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